Package 76420-210-60

{"route": ["ORAL"], "spl_id": "d9ae8825-f28b-ba4e-e053-2995a90a4487", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "unii": ["LW0TIW155Z"], "rxcui": ["311892"], "spl_set_id": ["04a71deb-2c9d-436c-a574-e5991b6a5248"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "7 TABLET in 1 BOTTLE (76420-210-07)", "package_ndc": "76420-210-07", "marketing_start_date": "20220308"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (76420-210-10)", "package_ndc": "76420-210-10", "marketing_start_date": "20220308"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (76420-210-14)", "package_ndc": "76420-210-14", "marketing_start_date": "20220308"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (76420-210-20)", "package_ndc": "76420-210-20", "marketing_start_date": "20220308"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-210-30)", "package_ndc": "76420-210-30", "marketing_start_date": "20220308"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-210-60)", "package_ndc": "76420-210-60", "marketing_start_date": "20220308"}], "brand_name": "Nabumetone", "product_id": "76420-210_d9ae8825-f28b-ba4e-e053-2995a90a4487", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "76420-210", "generic_name": "Nabumetone", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nabumetone", "active_ingredients": [{"name": "NABUMETONE", "strength": "500 mg/1"}], "application_number": "ANDA078420", "marketing_category": "ANDA", "marketing_start_date": "20190626", "listing_expiration_date": "20261231"}